Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$41.33 - $74.26 $1,157 - $2,079
-28 Reduced 35.9%
50 $2,000
Q1 2024

May 10, 2024

SELL
$56.27 - $73.77 $3,826 - $5,016
-68 Reduced 46.58%
78 $5,000
Q4 2023

Feb 29, 2024

SELL
$59.06 - $75.72 $9,744 - $12,493
-165 Reduced 53.05%
146 $10,000
Q4 2023

Feb 22, 2024

BUY
$59.06 - $75.72 $18,367 - $23,548
311 New
311 $23,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Scarborough Advisors, LLC Portfolio

Follow Scarborough Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scarborough Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scarborough Advisors, LLC with notifications on news.